Application 204696
- Type
- ANDA
- Sponsor
- SAGENT PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LINEZOLID | LINEZOLID | SOLUTION;INTRAVENOUS | 200MG/100ML (2MG/ML) | No | No |
| 002 | LINEZOLID | LINEZOLID | SOLUTION;INTRAVENOUS | 600MG/300ML (2MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204696-001 | LINEZOLID | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | |
| A204696-002 | LINEZOLID | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A204696-001 | AP |
| A204696-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A204696-001 | LINEZOLID | 200MG/100ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A204696-002 | LINEZOLID | 600MG/300ML (2MG/ML) | SOLUTION / INTRAVENOUS | AP | 2017-03-02 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A204696-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A204696-002 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A204696-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A204696-002 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A204696-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204696-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204696-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204696-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A204696-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204696-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204696-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204696-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204696-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204696-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204696-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204696-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204696-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204696-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204696-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204696-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204696-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204696-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A204696-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A204696-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204696-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204696-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204696-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204696-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204696-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204696-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A204696-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A204696-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204696-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204696-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A204696-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A204696-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A204696-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A204696-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A204696-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A204696-002 | AP | 1 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Linezolid | LINEZOLID | Bryant Ranch Prepack | 8a04bdc9-d6f0-4e35-b683-a472a2e4ff04 | 2025-08-26 | Warnings, Adverse reactions | Linezolid LINEZOLID |
| Linezolid | LINEZOLID | Bryant Ranch Prepack | ab1b4ab5-7338-4b01-963b-43eeb4c9cf1c | 2025-08-26 | Warnings, Adverse reactions | Linezolid LINEZOLID |
| Linezolid | LINEZOLID | Ascend Laboratories, LLC | 7402aa01-50de-46c8-a341-d30da5b32b1c | 2025-06-13 | Warnings, Adverse reactions | Linezolid LINEZOLID |
| Linezolid | LINEZOLID | Hikma Pharmaceuticals USA Inc. | fedbffa7-087d-4448-85c9-0350a3947080 | 2025-05-09 | Warnings, Adverse reactions | Linezolid LINEZOLID |
| Linezolid | LINEZOLID | Camber Pharmaceuticals, Inc. | b239458e-9a3e-49ac-9ac7-a4badc53dff6 | 2025-01-09 | Warnings, Adverse reactions | Linezolid LINEZOLID |
| Linezolid | LINEZOLID | American Health Packaging | bc12bd87-5ef0-4ebe-bc00-cbd7896ce08c | 2024-11-22 | Warnings, Adverse reactions | Linezolid LINEZOLID |
| Linezolid | LINEZOLID | Lupin Pharmaceuticals,Inc. | b3c55eb4-50f2-47f0-a424-5a6779518e1d | 2024-09-05 | Warnings, Adverse reactions | Linezolid LINEZOLID |
| Linezolid | LINEZOLID | Hp Halden Pharma AS | 217f3ee2-2534-4c32-8e9d-09b6d65df4af | 2024-07-17 | Warnings, Adverse reactions | Linezolid LINEZOLID |
| Zyvox | LINEZOLID | Hp Halden Pharma AS | b0c75e79-bf29-4f1d-a45d-ae28398a52d9 | 2024-05-28 | Warnings, Adverse reactions | LINEZOLID |
| Zyvox | LINEZOLID | Hp Halden Pharma AS | ce57225b-4580-442b-8c48-8045297cbb50 | 2024-05-28 | Warnings, Adverse reactions | LINEZOLID |
| Zyvox | LINEZOLID | Hp Halden Pharma AS | efe6818c-b798-4d1d-8196-6447a305ad71 | 2024-05-28 | Warnings, Adverse reactions | LINEZOLID |
| Linezolid | LINEZOLID | Fresenius Kabi USA, LLC | cc3e3ea4-50aa-49ee-a8bc-fb48bfc8e014 | 2024-04-30 | Warnings, Adverse reactions | Linezolid LINEZOLID |
| Linezolid | LINEZOLID | Camber Pharmaceuticals, Inc. | a89a37ec-a736-464b-a83a-84bef6ccd702 | 2023-09-15 | Warnings, Adverse reactions | Linezolid LINEZOLID |
| Linezolid | LINEZOLID | American Health Packaging | e9ac1ad7-7a23-463d-a467-f0ecc7e523e7 | 2023-08-18 | Warnings, Adverse reactions | Linezolid LINEZOLID |
| Linezolid | LINEZOLID | Alembic Pharmaceuticals Limited | 74f035ec-a0b1-4371-a17b-20b0b11864c9 | 2023-01-30 | Warnings, Adverse reactions | Linezolid LINEZOLID |
| Linezolid | LINEZOLID | Alembic Pharmaceuticals Inc. | ca930576-62ab-4af5-ac3e-27ca376baca6 | 2020-08-26 | Warnings, Adverse reactions | Linezolid LINEZOLID |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.